Cargando…
Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate
Cardiovascular death commonly occurs in patients with chronic kidney disease. Indoxyl sulfate (IS), a uremic toxin, has been demonstrated in vitro as a contributory factor in cardiac fibrosis, a typical pathological finding in uremic cardiomyopathy. This study aimed to determine if cardiac fibrosis...
Autores principales: | Lekawanvijit, Suree, Kompa, Andrew R., Manabe, Minako, Wang, Bing H., Langham, Robyn G., Nishijima, Fuyuhiko, Kelly, Darren J., Krum, Henry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3400638/ https://www.ncbi.nlm.nih.gov/pubmed/22829936 http://dx.doi.org/10.1371/journal.pone.0041281 |
Ejemplares similares
-
The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction
por: Lekawanvijit, Suree, et al.
Publicado: (2013) -
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015) -
Contribution of microRNA to pathological fibrosis in cardio-renal syndrome: impact of uremic toxins
por: Rana, Indrajeetsinh, et al.
Publicado: (2015) -
Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB
por: Bolati, Dilinaer, et al.
Publicado: (2013) -
Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome
por: Lekawanvijit, Suree
Publicado: (2018)